In this 17-year follow-up study of 948 people with Type 2 diabetes not using insulin, baseline depression only (defined as a high level of depressive symptoms, without a co-morbid high level of anxiety symptoms) was associated with a 39% increased mortality risk after adjustment for demographics, HbA1c, and comorbidities. This evidence concerns the gene INS and depressive disorder.